Arena Pharmaceuticals Inc ROCE
What is the ROCE of Arena Pharmaceuticals Inc?
The ROCE of Arena Pharmaceuticals Inc is -85.23%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Health Care sector on NASDAQ compared to Arena Pharmaceuticals Inc
What does Arena Pharmaceuticals Inc do?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Companies with roce similar to Arena Pharmaceuticals Inc
- Mersana Therapeutics Inc has ROCE of -86.13%
- Cidara Therapeutics Inc has ROCE of -86.02%
- Provention Bio has ROCE of -85.97%
- Avadel Pharmaceuticals plc has ROCE of -85.92%
- Future FinTech Inc has ROCE of -85.86%
- Angiodynamic Inc has ROCE of -85.31%
- Arena Pharmaceuticals Inc has ROCE of -85.23%
- Aimmune Therapeutics Inc has ROCE of -85.16%
- The McClatchy has ROCE of -85.09%
- Galmed Pharmaceuticals Ltd has ROCE of -84.75%
- Novan Inc has ROCE of -84.71%
- Hands Form Ltd has ROCE of -84.67%
- Sparq Corp has ROCE of -84.65%